452 related articles for article (PubMed ID: 25320284)
1. TCRs genetically linked to CD28 and CD3ε do not mispair with endogenous TCR chains and mediate enhanced T cell persistence and anti-melanoma activity.
Govers C; Sebestyén Z; Roszik J; van Brakel M; Berrevoets C; Szöőr Á; Panoutsopoulou K; Broertjes M; Van T; Vereb G; Szöllősi J; Debets R
J Immunol; 2014 Nov; 193(10):5315-26. PubMed ID: 25320284
[TBL] [Abstract][Full Text] [Related]
2. TCR gene-engineered T cell: limited T cell activation and combined use of IL-15 and IL-21 ensure minimal differentiation and maximal antigen-specificity.
Pouw N; Treffers-Westerlaken E; Mondino A; Lamers C; Debets R
Mol Immunol; 2010 Apr; 47(7-8):1411-20. PubMed ID: 20303179
[TBL] [Abstract][Full Text] [Related]
3. T-cell synapse formation depends on antigen recognition but not CD3 interaction: studies with TCR:ζ, a candidate transgene for TCR gene therapy.
Roszik J; Sebestyén Z; Govers C; Guri Y; Szöor A; Pályi-Krekk Z; Vereb G; Nagy P; Szöllosi J; Debets R
Eur J Immunol; 2011 May; 41(5):1288-97. PubMed ID: 21469084
[TBL] [Abstract][Full Text] [Related]
4. A functional role for CD28 costimulation in tumor recognition by single-chain receptor-modified T cells.
Moeller M; Haynes NM; Trapani JA; Teng MW; Jackson JT; Tanner JE; Cerutti L; Jane SM; Kershaw MH; Smyth MJ; Darcy PK
Cancer Gene Ther; 2004 May; 11(5):371-9. PubMed ID: 15060573
[TBL] [Abstract][Full Text] [Related]
5. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H
Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755
[TBL] [Abstract][Full Text] [Related]
6. Human T cells engineered to express a programmed death 1/28 costimulatory retargeting molecule display enhanced antitumor activity.
Ankri C; Shamalov K; Horovitz-Fried M; Mauer S; Cohen CJ
J Immunol; 2013 Oct; 191(8):4121-9. PubMed ID: 24026081
[TBL] [Abstract][Full Text] [Related]
7. Dynamic regulation of T-cell costimulation through TCR-CD28 microclusters.
Yokosuka T; Saito T
Immunol Rev; 2009 May; 229(1):27-40. PubMed ID: 19426213
[TBL] [Abstract][Full Text] [Related]
8. Gene transfer of human TCR in primary murine T cells is improved by pseudo-typing with amphotropic and ecotropic envelopes.
Pouw NM; Westerlaken EJ; Willemsen RA; Debets R
J Gene Med; 2007 Jul; 9(7):561-70. PubMed ID: 17471588
[TBL] [Abstract][Full Text] [Related]
9. Construction and molecular characterization of human chimeric T-cell antigen receptors specific for carcinoembryonic antigen.
Shirasu N; Shibaguci H; Kuroki M; Yamada H; Kuroki M
Anticancer Res; 2010 Jul; 30(7):2731-8. PubMed ID: 20683006
[TBL] [Abstract][Full Text] [Related]
10. Pertussis toxin utilizes proximal components of the T-cell receptor complex to initiate signal transduction events in T cells.
Schneider OD; Weiss AA; Miller WE
Infect Immun; 2007 Aug; 75(8):4040-9. PubMed ID: 17562776
[TBL] [Abstract][Full Text] [Related]
11. Expression of the costimulatory receptor CD30 is regulated by both CD28 and cytokines.
Gilfillan MC; Noel PJ; Podack ER; Reiner SL; Thompson CB
J Immunol; 1998 Mar; 160(5):2180-7. PubMed ID: 9498756
[TBL] [Abstract][Full Text] [Related]
12. The EMT/ITK/TSK (EMT) tyrosine kinase is activated during TCR signaling: LCK is required for optimal activation of EMT.
Gibson S; August A; Kawakami Y; Kawakami T; Dupont B; Mills GB
J Immunol; 1996 Apr; 156(8):2716-22. PubMed ID: 8609388
[TBL] [Abstract][Full Text] [Related]
13. A CD28-associated signaling pathway leading to cytokine gene transcription and T cell proliferation without TCR engagement.
Siefken R; Klein-Hessling S; Serfling E; Kurrle R; Schwinzer R
J Immunol; 1998 Aug; 161(4):1645-51. PubMed ID: 9712026
[TBL] [Abstract][Full Text] [Related]
14. Differential loss of T cell signaling molecules in metastatic melanoma patients' T lymphocyte subsets expressing distinct TCR variable regions.
Maccalli C; Pisarra P; Vegetti C; Sensi M; Parmiani G; Anichini A
J Immunol; 1999 Dec; 163(12):6912-23. PubMed ID: 10586094
[TBL] [Abstract][Full Text] [Related]
15. Transgenic TCR expression: comparison of single chain with full-length receptor constructs for T-cell function.
Zhang T; He X; Tsang TC; Harris DT
Cancer Gene Ther; 2004 Jul; 11(7):487-96. PubMed ID: 15153936
[TBL] [Abstract][Full Text] [Related]
16. T cell re-targeting to EBV antigens following TCR gene transfer: CD28-containing receptors mediate enhanced antigen-specific IFNgamma production.
Schaft N; Lankiewicz B; Drexhage J; Berrevoets C; Moss DJ; Levitsky V; Bonneville M; Lee SP; McMichael AJ; Gratama JW; Bolhuis RL; Willemsen R; Debets R
Int Immunol; 2006 Apr; 18(4):591-601. PubMed ID: 16507598
[TBL] [Abstract][Full Text] [Related]
17. T cell receptor-engineered T cells to treat solid tumors: T cell processing toward optimal T cell fitness.
Lamers CH; van Steenbergen-Langeveld S; van Brakel M; Groot-van Ruijven CM; van Elzakker PM; van Krimpen B; Sleijfer S; Debets R
Hum Gene Ther Methods; 2014 Dec; 25(6):345-57. PubMed ID: 25423330
[TBL] [Abstract][Full Text] [Related]
18. Adoptive antitumor immunotherapy in vitro and in vivo using genetically activated erbB2-specific T cells.
Wang C; Hu W; Shen L; Dou R; Zhao S; Shan D; Yu K; Huang R; Li H
J Immunother; 2014 Sep; 37(7):351-9. PubMed ID: 25075564
[TBL] [Abstract][Full Text] [Related]
19. Mycobacterial antigen(s) induce anergy by altering TCR- and TCR/CD28-induced signalling events: insights into T-cell unresponsiveness in leprosy.
Dagur PK; Sharma B; Kumar G; Khan NA; Katoch VM; Sengupta U; Joshi B
Mol Immunol; 2010 Feb; 47(5):943-52. PubMed ID: 20018378
[TBL] [Abstract][Full Text] [Related]
20. Anti-GD3 chimeric sFv-CD28/T-cell receptor zeta designer T cells for treatment of metastatic melanoma and other neuroectodermal tumors.
Lo AS; Ma Q; Liu DL; Junghans RP
Clin Cancer Res; 2010 May; 16(10):2769-80. PubMed ID: 20460472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]